Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
Feyaerts D, Hédou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudillière DK, Mukherjee N, Tsai AS, Rumer KK, Jacobsen DR, Bjornson-Hooper ZB, Jiang S, Saavedra SF, Valdés Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudillière B, McIlwain DR. Feyaerts D, et al. Among authors: valdes ferrer si. Cell Rep Med. 2022 Jul 19;3(7):100680. doi: 10.1016/j.xcrm.2022.100680. Epub 2022 Jun 28. Cell Rep Med. 2022. PMID: 35839768 Free PMC article.
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
Feyaerts D, Hédou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudillière DK, Mukherjee N, Tsai AS, Rumer KK, Jiang S, Valdés Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudillière B, McIlwain DR. Feyaerts D, et al. Among authors: valdes ferrer si. bioRxiv [Preprint]. 2021 Feb 10:2021.02.09.430269. doi: 10.1101/2021.02.09.430269. bioRxiv. 2021. PMID: 33594362 Free PMC article. Updated. Preprint.
Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study.
Núñez I, Gillard J, Fragoso-Saavedra S, Feyaerts D, Islas-Weinstein L, Gallegos-Guzmán AA, Valente-García U, Meyerowitz J, Kelly JD, Chen H, Ganio E, Benkendorff A, Flores-Gouyonnet J, Dammann-Beltrán P, Heredia-González JF, Rangel-Gutiérrez GA, Blish CA, Nadeau KC, Nolan G, Crispín JC, McIlwain DR, Gaudillière B, Valdés-Ferrer SI. Núñez I, et al. Among authors: valdes ferrer si. Front Med (Lausanne). 2023 Aug 24;10:1236702. doi: 10.3389/fmed.2023.1236702. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37727759 Free PMC article.
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, García-González HB, Nuñez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Martínez S, Caro-Vega Y, Calva JJ, Luqueño-Martínez V, González-Duarte A, Crabtree-Ramírez B, Crispín JC, Sierra-Madero J, Belaunzarán-Zamudio PF, Valdés-Ferrer SI. Fragoso-Saavedra S, et al. Among authors: valdes ferrer si. BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7. BMC Infect Dis. 2020. PMID: 33066761 Free PMC article.
Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City.
Flores-Silva FD, García-Grimshaw M, Valdés-Ferrer SI, Vigueras-Hernández AP, Domínguez-Moreno R, Tristán-Samaniego DP, Michel-Chávez A, González-Duarte A, Vega-Boada FA, Reyes-Melo I, Jiménez-Ruiz A, Chávez-Martínez OA, Rebolledo-García D, Marché-Fernández OA, Sánchez-Torres S, García-Ramos G, Cantú-Brito C, Chiquete E. Flores-Silva FD, et al. Among authors: valdes ferrer si. PLoS One. 2021 Apr 8;16(4):e0247433. doi: 10.1371/journal.pone.0247433. eCollection 2021. PLoS One. 2021. PMID: 33831042 Free PMC article. Clinical Trial.
Delirium and Associated Factors in a Cohort of Hospitalized Patients With Coronavirus Disease 2019.
García-Grimshaw M, Chiquete E, Jiménez-Ruiz A, Vidal-Mayo JJ, Grajeda-González SL, Vargas-Martínez MLÁ, Toapanta-Yanchapaxi LN, Valdés-Ferrer SI, Chávez-Martínez OA, Marché-Fernández OA, Jiménez-Ávila AI, Cantú-Brito C, Flores-Silva FD. García-Grimshaw M, et al. Among authors: valdes ferrer si. J Acad Consult Liaison Psychiatry. 2022 Jan-Feb;63(1):3-13. doi: 10.1016/j.jaclp.2021.06.008. Epub 2021 Jul 6. J Acad Consult Liaison Psychiatry. 2022. PMID: 34242847 Free PMC article.
Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis.
García-Grimshaw M, Chirino-Pérez A, Flores-Silva FD, Valdés-Ferrer SI, Vargas-Martínez MLÁ, Jiménez-Ávila AI, Chávez-Martínez OA, Ramos-Galicia EM, Marché-Fernández OA, Ramírez-Carrillo MF, Grajeda-González SL, Ramírez-Jiménez ME, Chávez-Manzanera EA, Tusié-Luna MT, Ochoa-Guzmán A, Cantú-Brito C, Fernandez-Ruiz J, Chiquete E. García-Grimshaw M, et al. Among authors: valdes ferrer si. Neurol Sci. 2022 Apr;43(4):2217-2229. doi: 10.1007/s10072-021-05798-8. Epub 2022 Jan 13. Neurol Sci. 2022. PMID: 35022935 Free PMC article.
69 results